| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.801 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.721 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.559 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.546 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.543 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.531 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.481 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.437 | |
| angiotensin activated signaling pathway | GO:0038166 | 4 | 0.434 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.420 | |
| limb development | GO:0060173 | 166 | 0.411 | |
| vasoconstriction | GO:0042310 | 27 | 0.386 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.385 | |
| skeletal system development | GO:0001501 | 356 | 0.373 | Mouse |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.371 | Mouse |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.371 | |
| extracellular structure organization | GO:0043062 | 148 | 0.369 | Mouse Worm |
| collagen fibril organization | GO:0030199 | 32 | 0.350 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.346 | |
| regulation of lung blood pressure | GO:0014916 | 2 | 0.336 | |
| amine metabolic process | GO:0009308 | 45 | 0.276 | |
| sterol esterification | GO:0034434 | 3 | 0.267 | |
| positive regulation of monooxygenase activity | GO:0032770 | 2 | 0.261 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.256 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.254 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.252 | |
| cell chemotaxis | GO:0060326 | 81 | 0.244 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.242 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.238 | Mouse |
| fused antrum stage | GO:0048165 | 1 | 0.234 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.230 | |
| vasodilation | GO:0042311 | 28 | 0.229 | |
| response to sterol | GO:0036314 | 4 | 0.222 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.222 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.219 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.219 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.211 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.208 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.208 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.208 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.200 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.199 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.198 | |
| blood circulation | GO:0008015 | 195 | 0.193 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.187 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.184 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.183 | |
| respiratory system development | GO:0060541 | 190 | 0.181 | Mouse |
| regulation of tolerance induction to self antigen | GO:0002649 | 1 | 0.178 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.174 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.171 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.167 | |
| circulatory system process | GO:0003013 | 197 | 0.167 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.166 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.164 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.160 | Mouse |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.155 | |
| growth plate cartilage development | GO:0003417 | 14 | 0.153 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.151 | |
| negative regulation of blood circulation | GO:1903523 | 15 | 0.148 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.141 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.140 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.140 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.139 | |
| sterol metabolic process | GO:0016125 | 58 | 0.132 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.130 | |
| regulation of vasoconstriction | GO:0019229 | 14 | 0.130 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.129 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.127 | |
| maintenance of protein location in nucleus | GO:0051457 | 2 | 0.124 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.124 | |
| oxidation reduction process | GO:0055114 | 342 | 0.122 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.122 | |
| bone development | GO:0060348 | 120 | 0.122 | Mouse |
| limb morphogenesis | GO:0035108 | 149 | 0.121 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.117 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.117 | Mouse |
| regulation of cell migration | GO:0030334 | 219 | 0.117 | |
| mesoderm structural organization | GO:0048338 | 1 | 0.117 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.117 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.117 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.115 | |
| response to growth factor | GO:0070848 | 198 | 0.115 | Mouse |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.115 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.114 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.113 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.112 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.112 | |
| appendage development | GO:0048736 | 166 | 0.109 | |
| neural plate mediolateral regionalization | GO:0021998 | 1 | 0.108 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.106 | |
| cartilage development involved in endochondral bone morphogenesis | GO:0060351 | 24 | 0.106 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.105 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.105 | Mouse |
| cholesterol import | GO:0070508 | 2 | 0.104 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.103 | Mouse Worm |
| response to oxidative stress | GO:0006979 | 123 | 0.103 | Mouse |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.102 | |
| negative regulation of vasoconstriction | GO:0045906 | 2 | 0.100 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.100 | |
| b cell tolerance induction | GO:0002514 | 2 | 0.100 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.099 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.099 | |
| regulation of system process | GO:0044057 | 200 | 0.096 | |
| regulation of cell motility | GO:2000145 | 236 | 0.095 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.095 | |
| negative regulation of heart contraction | GO:0045822 | 11 | 0.095 | |
| positive regulation of tolerance induction to self antigen | GO:0002651 | 1 | 0.095 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.095 | |
| respiratory tube development | GO:0030323 | 167 | 0.095 | Mouse |
| phospholipid catabolic process | GO:0009395 | 5 | 0.094 | |
| response to alcohol | GO:0097305 | 48 | 0.094 | |
| cholesterol esterification | GO:0034435 | 3 | 0.094 | |
| lipid catabolic process | GO:0016042 | 69 | 0.093 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.093 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.091 | |
| response to oxygen levels | GO:0070482 | 62 | 0.090 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.090 | |
| lens fiber cell apoptotic process | GO:1990086 | 4 | 0.088 | |
| cellular zinc ion homeostasis | GO:0006882 | 9 | 0.088 | |
| protein hydroxylation | GO:0018126 | 4 | 0.088 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.088 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.087 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.086 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.086 | |
| positive regulation of t cell tolerance induction | GO:0002666 | 6 | 0.085 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.085 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.083 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.081 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.081 | |
| regulation of anti mullerian hormone signaling pathway | GO:1902612 | 1 | 0.081 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.080 | |
| cellular response to osmotic stress | GO:0071470 | 7 | 0.080 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.079 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.079 | |
| bronchus morphogenesis | GO:0060434 | 2 | 0.079 | |
| regulation of protein localization | GO:0032880 | 231 | 0.079 | |
| regulation of response to osmotic stress | GO:0047484 | 3 | 0.077 | |
| regulation of cellular senescence | GO:2000772 | 6 | 0.077 | |
| regulation of tube size | GO:0035150 | 57 | 0.076 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.075 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.074 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.073 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.072 | |
| common partner smad protein phosphorylation | GO:0007182 | 2 | 0.072 | |
| lung development | GO:0030324 | 164 | 0.070 | Mouse |
| response to cholesterol | GO:0070723 | 4 | 0.070 | |
| inflammatory response | GO:0006954 | 244 | 0.070 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.070 | |
| response to cell cycle checkpoint signaling | GO:0072396 | 1 | 0.069 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.069 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.069 | |
| forebrain development | GO:0030900 | 302 | 0.069 | |
| chemotaxis | GO:0006935 | 247 | 0.068 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.066 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.066 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.066 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.064 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.063 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.063 | |
| protein catabolic process | GO:0030163 | 221 | 0.063 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.062 | |
| phospholipid transport | GO:0015914 | 21 | 0.062 | |
| odontogenesis | GO:0042476 | 78 | 0.062 | |
| steroid metabolic process | GO:0008202 | 119 | 0.061 | |
| renal system development | GO:0072001 | 225 | 0.061 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.060 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.060 | |
| ovarian follicle development | GO:0001541 | 40 | 0.060 | |
| leukocyte migration | GO:0050900 | 124 | 0.060 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.059 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.058 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.057 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.057 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.056 | |
| maintenance of location | GO:0051235 | 89 | 0.056 | |
| negative regulation of anti mullerian hormone signaling pathway | GO:1902613 | 1 | 0.056 | |
| lipid homeostasis | GO:0055088 | 63 | 0.056 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.055 | |
| positive regulation of dendrite development | GO:1900006 | 21 | 0.055 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.054 | Mouse |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.053 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.053 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.053 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.053 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.053 | |
| endochondral bone growth | GO:0003416 | 19 | 0.052 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.052 | |
| response to hyperoxia | GO:0055093 | 2 | 0.052 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.051 | |
| positive regulation of filopodium assembly | GO:0051491 | 10 | 0.051 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.051 | |
| growth plate cartilage chondrocyte development | GO:0003431 | 3 | 0.051 | |
| regulation of cell projection assembly | GO:0060491 | 38 | 0.051 | |
| body morphogenesis | GO:0010171 | 45 | 0.050 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.049 | |
| steroid esterification | GO:0034433 | 3 | 0.049 | |
| male gamete generation | GO:0048232 | 285 | 0.049 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.048 | |
| anti mullerian hormone signaling pathway | GO:1990262 | 1 | 0.048 | |
| indolalkylamine metabolic process | GO:0006586 | 4 | 0.047 | |
| dendrite development | GO:0016358 | 115 | 0.047 | |
| muscle tissue development | GO:0060537 | 308 | 0.046 | |
| regulation of b cell tolerance induction | GO:0002661 | 2 | 0.046 | |
| camera type eye development | GO:0043010 | 266 | 0.046 | |
| regulation of monooxygenase activity | GO:0032768 | 7 | 0.045 | |
| dna repair | GO:0006281 | 107 | 0.045 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.044 | |
| molting cycle | GO:0042303 | 90 | 0.044 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.043 | |
| positive regulation of interferon gamma secretion | GO:1902715 | 3 | 0.043 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.043 | |
| regulation of smad protein import into nucleus | GO:0060390 | 3 | 0.043 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.043 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.043 | |
| organ regeneration | GO:0031100 | 2 | 0.043 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.043 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.042 | |
| ovarian cumulus expansion | GO:0001550 | 1 | 0.042 | |
| lipid modification | GO:0030258 | 65 | 0.041 | |
| cholesterol transport | GO:0030301 | 38 | 0.041 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.041 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.041 | Mouse |
| regulation of secretion by cell | GO:1903530 | 249 | 0.041 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.041 | |
| mullerian duct regression | GO:0001880 | 1 | 0.041 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.041 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.040 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.040 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.040 | Mouse |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.040 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.040 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.040 | |
| regulation of axon extension | GO:0030516 | 43 | 0.039 | |
| stem cell differentiation | GO:0048863 | 268 | 0.039 | |
| cartilage development | GO:0051216 | 140 | 0.039 | Mouse |
| superoxide anion generation | GO:0042554 | 11 | 0.039 | |
| actin filament polymerization | GO:0030041 | 44 | 0.039 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.039 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.039 | |
| negative regulation of cardiac muscle tissue growth | GO:0055022 | 7 | 0.039 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.039 | |
| endocytosis | GO:0006897 | 168 | 0.038 | |
| copper ion transmembrane transport | GO:0035434 | 5 | 0.038 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.038 | |
| chondrocyte development | GO:0002063 | 24 | 0.038 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.038 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.038 | |
| myeloid dendritic cell activation | GO:0001773 | 25 | 0.037 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.037 | |
| positive regulation of triglyceride biosynthetic process | GO:0010867 | 6 | 0.037 | |
| humoral immune response | GO:0006959 | 57 | 0.037 | |
| response to monosaccharide | GO:0034284 | 67 | 0.036 | |
| acetylcholine transport | GO:0015870 | 2 | 0.036 | |
| sterol homeostasis | GO:0055092 | 45 | 0.036 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.036 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.036 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.036 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.036 | |
| peptidyl proline hydroxylation | GO:0019511 | 3 | 0.036 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.036 | |
| growth plate cartilage chondrocyte growth | GO:0003430 | 2 | 0.036 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.035 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.035 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.035 | |
| positive regulation of tolerance induction | GO:0002645 | 8 | 0.035 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.035 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.035 | |
| cytokine production | GO:0001816 | 319 | 0.035 | |
| response to estrogen | GO:0043627 | 24 | 0.035 | |
| negative regulation of neurotrophin trk receptor signaling pathway | GO:0051387 | 2 | 0.034 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.034 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.034 | |
| regulation of secretion | GO:0051046 | 274 | 0.034 | |
| membrane protein proteolysis | GO:0033619 | 10 | 0.034 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.034 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.033 | |
| innate immune response | GO:0045087 | 157 | 0.033 | |
| rhythmic process | GO:0048511 | 174 | 0.033 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.033 | |
| venous blood vessel development | GO:0060841 | 13 | 0.032 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.032 | |
| epithelial cell migration | GO:0010631 | 63 | 0.032 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.032 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 4 | 0.032 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.032 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.032 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.031 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.031 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.031 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.031 | |
| sterol import | GO:0035376 | 2 | 0.031 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.031 | |
| response to dietary excess | GO:0002021 | 18 | 0.031 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.031 | |
| kidney development | GO:0001822 | 213 | 0.031 | |
| peptide metabolic process | GO:0006518 | 46 | 0.031 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.031 | |
| organelle assembly | GO:0070925 | 177 | 0.030 | |
| lateral mesoderm formation | GO:0048370 | 3 | 0.030 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.030 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.030 | |
| connective tissue development | GO:0061448 | 179 | 0.030 | Mouse |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.030 | |
| regulation of neuron death | GO:1901214 | 134 | 0.030 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.030 | Mouse |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.030 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.030 | |
| cell recognition | GO:0008037 | 83 | 0.029 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.029 | |
| regulation of protein binding | GO:0043393 | 60 | 0.029 | |
| lysosome organization | GO:0007040 | 21 | 0.029 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.029 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.029 | |
| negative regulation of metalloenzyme activity | GO:0048553 | 2 | 0.029 | |
| neuron death | GO:0070997 | 154 | 0.028 | |
| regulation of filopodium assembly | GO:0051489 | 13 | 0.028 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.028 | |
| ossification | GO:0001503 | 216 | 0.028 | Mouse |
| intracellular protein transport | GO:0006886 | 204 | 0.028 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.027 | |
| transmembrane transport | GO:0055085 | 412 | 0.027 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.027 | |
| bone morphogenesis | GO:0060349 | 78 | 0.027 | Mouse |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.027 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.027 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.027 | |
| transition metal ion transport | GO:0000041 | 38 | 0.027 | |
| positive regulation of protein secretion | GO:0050714 | 52 | 0.027 | |
| digestive tract development | GO:0048565 | 190 | 0.027 | |
| skin development | GO:0043588 | 220 | 0.027 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.027 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.026 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.026 | |
| cellular response to lipid | GO:0071396 | 145 | 0.026 | |
| response to ketone | GO:1901654 | 15 | 0.026 | |
| glycerophospholipid catabolic process | GO:0046475 | 5 | 0.026 | |
| negative regulation of endothelial cell differentiation | GO:0045602 | 2 | 0.026 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.026 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.026 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.026 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.025 | |
| stress response to metal ion | GO:0097501 | 3 | 0.025 | |
| response to metal ion | GO:0010038 | 47 | 0.025 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.025 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.025 | |
| acetate ester transport | GO:1901374 | 2 | 0.025 | |
| reelin mediated signaling pathway | GO:0038026 | 3 | 0.025 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.025 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.025 | |
| male gonad development | GO:0008584 | 88 | 0.025 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.025 | |
| axonogenesis | GO:0007409 | 274 | 0.025 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.025 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.025 | |
| mesendoderm development | GO:0048382 | 3 | 0.025 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.025 | |
| positive regulation of axon guidance | GO:1902669 | 5 | 0.024 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.024 | |
| t cell tolerance induction | GO:0002517 | 6 | 0.024 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.024 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.024 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.024 | Mouse |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.024 | |
| oogenesis stage | GO:0022605 | 3 | 0.024 | |
| antibacterial peptide biosynthetic process | GO:0002780 | 2 | 0.024 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.024 | |
| regulation of cell size | GO:0008361 | 72 | 0.024 | |
| lateral mesodermal cell fate specification | GO:0048377 | 2 | 0.023 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.023 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.023 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.023 | |
| fat cell differentiation | GO:0045444 | 160 | 0.023 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.023 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.023 | |
| negative regulation of growth | GO:0045926 | 99 | 0.023 | |
| response to iron ion | GO:0010039 | 4 | 0.023 | |
| activation of immune response | GO:0002253 | 138 | 0.023 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.023 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.023 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.023 | |
| layer formation in cerebral cortex | GO:0021819 | 13 | 0.022 | |
| response to drug | GO:0042493 | 75 | 0.022 | |
| positive regulation of growth | GO:0045927 | 104 | 0.022 | |
| regeneration | GO:0031099 | 38 | 0.022 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.022 | |
| neurotrophin trk receptor signaling pathway | GO:0048011 | 8 | 0.022 | |
| cation homeostasis | GO:0055080 | 212 | 0.022 | |
| regulation of morphogenesis of a branching structure | GO:0060688 | 53 | 0.022 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.022 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.022 | |
| cgmp biosynthetic process | GO:0006182 | 13 | 0.022 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.021 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.021 | |
| peptide secretion | GO:0002790 | 114 | 0.021 | |
| phosphatidylcholine metabolic process | GO:0046470 | 13 | 0.021 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.021 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.021 | |
| dendritic spine development | GO:0060996 | 30 | 0.021 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.021 | |
| regulation of protein transport | GO:0051223 | 163 | 0.021 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.021 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| lateral mesoderm morphogenesis | GO:0048369 | 3 | 0.021 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.021 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.021 | |
| angiogenesis | GO:0001525 | 201 | 0.021 | |
| filopodium assembly | GO:0046847 | 19 | 0.020 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.020 | |
| organic anion transport | GO:0015711 | 137 | 0.020 | |
| kidney epithelium development | GO:0072073 | 121 | 0.020 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.020 | |
| autophagy | GO:0006914 | 45 | 0.020 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.020 | |
| response to amino acid | GO:0043200 | 37 | 0.020 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.020 | |
| nucleotide sugar metabolic process | GO:0009225 | 4 | 0.020 | |
| positive regulation of phosphoprotein phosphatase activity | GO:0032516 | 1 | 0.020 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.020 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.020 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.020 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.019 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.019 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.019 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.019 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.019 | |
| hormone secretion | GO:0046879 | 128 | 0.019 | Mouse |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.019 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.019 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.019 | |
| tissue migration | GO:0090130 | 68 | 0.019 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.019 | |
| myosin filament assembly | GO:0031034 | 2 | 0.019 | |
| maternal placenta development | GO:0001893 | 20 | 0.019 | |
| positive regulation of axon extension | GO:0045773 | 20 | 0.019 | |
| synaptic transmission | GO:0007268 | 329 | 0.019 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.018 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.018 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.018 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.018 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.018 | |
| smooth muscle cell apoptotic process | GO:0034390 | 5 | 0.018 | |
| lipid localization | GO:0010876 | 126 | 0.018 | |
| response to glucagon | GO:0033762 | 3 | 0.018 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.018 | |
| endothelial cell migration | GO:0043542 | 44 | 0.018 | |
| positive regulation of dendritic spine development | GO:0060999 | 12 | 0.018 | |
| antimicrobial peptide secretion | GO:0002776 | 1 | 0.018 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.018 | |
| regulation of dendritic spine development | GO:0060998 | 22 | 0.018 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.018 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.018 | Mouse |
| cerebellar cortex development | GO:0021695 | 48 | 0.018 | |
| regulation of actin filament polymerization | GO:0030833 | 38 | 0.018 | |
| anatomical structure maturation | GO:0071695 | 49 | 0.018 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.018 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.018 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.018 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.017 | |
| axon guidance | GO:0007411 | 141 | 0.017 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.017 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.017 | |
| anatomical structure arrangement | GO:0048532 | 20 | 0.017 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.017 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.017 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.017 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.017 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.017 | |
| metencephalon development | GO:0022037 | 89 | 0.017 | |
| lateral mesodermal cell fate commitment | GO:0048372 | 2 | 0.017 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.017 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.017 | |
